Rifampicin Capsules

DRUG4 trials

Sponsors

Jiangsu HengRui Medicine Co., Ltd., Suzhou Zelgen Biopharmaceuticals Co.,Ltd, Xuanzhu Biopharmaceutical Co., Ltd., Guangzhou Lupeng Pharmaceutical Company LTD.

Conditions

Clinical PharmacologyDrug-drug Interaction StudyHealthy VolunteersNeoplasms

Phase 1

Effect of Rifampicin on the Pharmacokinetics of Apatinib

CompletedNCT02836821

Jiangsu HengRui Medicine Co., Ltd.Neoplasms

Start: 2016-05-31End: 2017-02-28Updated: 2017-02-27

A Study to Evaluate the Effect of Itraconazole and Rifampicin on the Pharmacokinetics of Jaktinib in Healthy Volunteers

CompletedNCT06246695

Suzhou Zelgen Biopharmaceuticals Co.,LtdHealthy Volunteers

Start: 2021-10-27End: 2022-01-12Updated: 2024-02-07

A Study Evaluating the Effects of Itraconazole or Rifampin on the Pharmacokinetic Characteristics of Rocbrutinib Tablet

RecruitingNCT07374224

Guangzhou Lupeng Pharmaceutical Company LTD.Clinical Pharmacology

Start: 2026-03-05End: 2026-08-30Target: 28Updated: 2026-03-09

Phase 4

Drug-drug Interaction Study of Rifampin and Anaprazole Sodium

Not yet recruitingNCT07330531

Xuanzhu Biopharmaceutical Co., Ltd.Drug-drug Interaction Study

Start: 2026-01-04End: 2027-07-21Target: 24Updated: 2026-01-09